| 2026-05-21 |
详情>>
内部人交易：
Chilton Kevin P.等共交易8笔
|
| 2026-05-05 |
详情>>
股本变动：
变动后总股本103031.11万股
|
| 2026-05-05 |
详情>>
业绩披露：
2026年一季报每股收益-0.2美元,归母净利润-2亿美元,同比去年增长0.50%
|
| 2026-05-05 |
财报披露：
美东时间 2026-05-05 盘后发布财报
|
| 2026-04-06 |
股东大会：
将于2026-05-20召开股东大会
会议内容 ▼▲
- 1.Elect the 9 director nominees named in this proxy statement
2.Ratify the appointment of KPMG LLP as our independent auditor for 2026
3.Approve amendments to our Articles of Incorporation to remove supermajority voting requirements
4.Approve an amendment to our Articles of Incorporation to provide for exceptions to the “Related Person” Definition
5.Approval of Amended and Restated 2024 Equity Incentive Plan
6.Approve, on an advisory (non-binding) basis, of the compensation of our named executive officers
7.Shareholder proposal requesting a shareholder right to vote for or against a poison pill
|
| 2026-02-20 |
详情>>
业绩披露：
2023年年报每股收益-10.48美元,归母净利润-102.98亿美元,同比去年增长-565.25%
|
| 2026-02-20 |
详情>>
业绩披露：
2025年年报每股收益-1.75美元,归母净利润-17.39亿美元,同比去年增长-3061.82%
|
| 2025-10-30 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.75美元,归母净利润-17.37亿美元,同比去年增长-1140.71%
|
| 2025-07-31 |
详情>>
业绩披露：
2025年中报每股收益-1.12美元,归母净利润-11.16亿美元,同比去年增长-14050%
|
| 2025-05-01 |
详情>>
业绩披露：
2025年一季报每股收益-0.2美元,归母净利润-2.01亿美元,同比去年增长-452.63%
|
| 2025-03-31 |
股东大会：
将于2025-05-13召开股东大会
会议内容 ▼▲
- 1.Elect the 11 director nominees named in this proxy statement
2.Ratify the appointment of KPMG LLP as our independent auditor for 2025
3.Amend our Articles of Incorporation to authorize a reverse stock split and a related reduction in our authorized Common Shares
4.Approve technical amendments and updates to our Articles of Incorporation
5.Advisory Vote on Executive Compensation – “Say-On-Pay”
6.Shareholder proposal regarding simple majority voting
|
| 2025-02-20 |
详情>>
业绩披露：
2022年年报每股收益-1.54美元,归母净利润-15.48亿美元,同比去年增长-176.14%
|
| 2025-02-20 |
详情>>
业绩披露：
2024年年报每股收益-0.06美元,归母净利润-5500万美元,同比去年增长99.47%
|
| 2024-11-05 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.14美元,归母净利润-1.4亿美元,同比去年增长98.31%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益0.01美元,归母净利润800.00万美元,同比去年增长100.10%
|
| 2024-04-30 |
详情>>
业绩披露：
2024年一季报每股收益0.06美元,归母净利润5700.00万美元,同比去年增长-88.85%
|
| 2024-04-05 |
股东大会：
将于2024-05-15召开股东大会
会议内容 ▼▲
- 1.Elect the 11 Director nominees named in this proxy statement
2.Ratify the appointment of KPMG LLP as our independent auditor for 2024
3.Approve our 2024 Equity Incentive Plan
4.Ratify the Amendment and Restatement of our NOL Rights Plan
5.Approval amendments to our Articles of Incorporation to:(a)Authorize a reverse stock split of our Common Shares.(b)Reduce the number of our authorized Common Shares, subject to the conditions specified herein.(c)Eliminate the par value of our Common Shares.
6.Advisory Vote on Executive Compensation – “Say-On-Pay”
|
| 2023-06-06 |
复牌提示：
2023-06-05 13:40:15 停牌，复牌日期 2023-06-05 14:02:04
|
| 2023-04-05 |
股东大会：
将于2023-05-17召开股东大会
会议内容 ▼▲
- 1.Elect the 10 Director nominees named in this proxy statement
2.Ratify the appointment of KPMG LLP as our independent auditor for 2023
3.Approval of Our Second Amended and Restated 2018 Equity Incentive Plan
4.Conduct a non-binding advisory vote to approve our executive compensation
5.Conduct a non-binding advisory vote regarding the frequency of our executive compensation votes
|
| 2022-04-08 |
股东大会：
将于2022-05-18召开股东大会
会议内容 ▼▲
- 1.Elect the 11 Director nominees named in this proxy statement
2.Ratify the appointment of KPMG LLP as our independent auditor for 2022
3.Conduct a non-binding advisory vote to approve our executive compensation
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-07 |
股东大会：
将于2021-05-19召开股东大会
会议内容 ▼▲
- 1.Elect the 11 Director nominees named in this proxy statement
2.Ratify the appointment of KPMG LLP as our independent auditor for 2021
3.Ratify the amendment to our Amended and Restated NOL Rights Plan described in this proxy statement
4.Conduct a non-binding advisory vote to approve our executive compensation
5.Transact other business that may properly come before the annual meeting
|
| 2020-04-08 |
股东大会：
将于2020-05-20召开股东大会
会议内容 ▼▲
- 1.Elect as directors the 11 nominees named in the accompanying proxy statement
2.Ratify the appointment of KPMG LLP as our independent auditor for 2020
3.Approve an amendment to our 2018 Equity Incentive Plan
4.Conduct a non-binding advisory vote to approve our executive compensation
5.Transact such other business as may properly come before the meeting and any adjournment
|
| 2019-04-10 |
股东大会：
将于2019-05-22召开股东大会
会议内容 ▼▲
- 1.Elect as directors the 13 nominees named in the accompanying proxy statement
2.Ratify the appointment of KPMG LLP as our independent auditor for 2019
3.Amend our Articles of Incorporation to increase our authorized shares of common stock
4.Ratify our NOL Rights Plan described herein
5.Conduct a non-binding advisory vote to approve our executive compensation
6.Act upon a shareholder proposal regarding our lobbying activities, if properly presented at the meeting
7.Transact such other business as may properly come before the meeting and any adjournment
|
| 2018-04-12 |
股东大会：
将于2018-05-23召开股东大会
会议内容 ▼▲
- 1.Elect as directors the 13 nominees named in the accompanying proxy statement
2.Ratify the appointment of KPMG LLP as our independent auditor for 2018
3.Approve our 2018 Equity Incentive Plan
4.Conduct a non-binding advisory vote regarding our executive compensation
5.Act upon two separate shareholder proposals if properly presented at the meeting
6.Transact such other business as may properly come before the meeting and any adjournment.
|
| 2017-04-13 |
股东大会：
将于2017-05-24召开股东大会
会议内容 ▼▲
- (1)Elect as directors the nine nominees named in the accompanying proxy statement
(2)Ratify the appointment of KPMG LLP as our independent auditor for 2017
(3)Conduct non-binding advisory votes:
(a)to approve our executive compensation
(b)regarding the frequency of our executive compensation votes
(4)Act upon three separate shareholder proposals if properly presented at the meeting
(5)Transact such other business as may properly come before the meeting and any adjournment.
|
| 2017-02-09 |
股东大会：
将于2017-03-16召开股东大会
会议内容 ▼▲
- 1. to vote on a proposal to approve the issuance of CenturyLink common stock to Level 3 stockholders in connection with the combination, as contemplated by the merger agreement, dated October 31, 2016, among CenturyLink, Inc., Wildcat Merger Sub 1 LLC, WWG Merger Sub LLC and Level 3 Communications, Inc., which we refer to as the merger agreement, a copy of which is attached as Annex A to the joint proxy statement/prospectus accompanying this notice, as such agreement may be amended from time to time (we refer to this proposal as the CenturyLink stock issuance proposal);
2. to vote on an adjournment of the CenturyLink special meeting, if necessary, to solicit additional proxies if there are not sufficient votes for the proposal to issue CenturyLink common stock in connection with the combination (we refer to this proposal as the CenturyLink adjournment proposal).
|